FBXO33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.473440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.091400E-01
Normal-vs-Stage2
8.946100E-02
Normal-vs-Stage3
5.161900E-03
Normal-vs-Stage4
3.812400E-01
Stage1-vs-Stage2
8.238100E-02
Stage1-vs-Stage3
7.308400E-02
Stage1-vs-Stage4
6.004800E-01
Stage2-vs-Stage3
1.283580E-01
Stage2-vs-Stage4
6.510000E-01
Stage3-vs-Stage4
1.674570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.554450E-01
Normal-vs-AfricanAmerican
2.554400E-01
Normal-vs-Asian
7.792300E-02
Caucasian-vs-AfricanAmerican
8.530000E-01
Caucasian-vs-Asian
2.547000E-01
AfricanAmerican-vs-Asian
3.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.000410E-01
Normal-vs-Female
2.319200E-01
Male-vs-Female
1.940220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.637800E-01
Normal-vs-Age(41-60Yrs)
3.957000E-01
Normal-vs-Age(61-80Yrs)
7.912300E-02
Normal-vs-Age(81-100Yrs)
7.121500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.944800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.470000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.244200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.783070E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.162200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.696400E-02
Normal-vs-Daily Drinker
1.608220E-01
Normal-vs-Weekly Drinker
6.722100E-02
Normal-vs-Occasional Drinker
4.048200E-01
Normal-vs-Social Drinker
3.378000E-01
Non Drinker-vs-Daily Drinker
2.993800E-01
Non Drinker-vs-Weekly Drinker
7.724000E-01
Non Drinker-vs-Occasional Drinker
3.996300E-02
Non Drinker-vs-Social Drinker
1.356970E-01
Daily Drinker-vs-Weekly Drinker
5.685800E-01
Daily Drinker-vs-Occasional Drinker
3.388200E-01
Daily Drinker-vs-Social Drinker
6.018800E-01
Weekly Drinker-vs-Occasional Drinker
1.623450E-01
Weekly Drinker-vs-Social Drinker
3.325600E-01
Occasional Drinker-vs-Social Drinker
7.359000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.692620E-01
Normal-vs-Grade 2
5.112100E-02
Normal-vs-Grade 3
5.048300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.288400E-01
Grade 1-vs-Grade 3
3.693200E-01
Grade 1-vs-Grade 4
1.692620E-01
Grade 2-vs-Grade 3
5.966400E-01
Grade 2-vs-Grade 4
5.112100E-02
Grade 3-vs-Grade 4
5.048300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.784000E-02
Normal-vs-NonDiabetic
1.369780E-01
Diabetic-vs-NonDiabetic
5.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.456930E-03
Normal-vs-NoPancreatitis
1.416160E-01
Pancreatitis-vs-NoPancreatitis
8.936200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.411800E-01
Normal-vs-N1
9.688400E-02
N0-vs-N1
9.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.565600E-02
Normal-vs-TP53-NonMutant
4.473600E-01
TP53-Mutant-vs-TP53-NonMutant
2.439800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
